Abstract
The purpose of the current study was to mask the taste of cetirizine HCl and to incorporate the granules produced in oral disintegrating tablets (ODT). The bitter, active substance was coated by fluidized bed coating using Eudragit® RL30-D at levels between 15% and 40% w/w. The ODTs were developed by varying the ratio of superdisintegrants such as sodium croscarmellose, crospovidone grades and low substituted hydroxypropyl cellulose (L-HPC). A direct compression process was used to compress the ODTs under various compaction forces to optimize tablet robustness. The properties of the compressed tablets including porosity, hardness, friability and dissolution profiles were further investigated. The in vitro and in vivo evaluation of the tablet disintegration times showed almost identical rapid disintegration below 10 s at the optimal levels of each superdisintegrant. Finally, the taste and sensory evaluation in human volunteers demonstrated excellence in masking the bitter active and tablet palatability.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Habibh W, Khankarik R, Hontz J. Fast-dissolve drug delivery system. Crit Rev Ther Drug Carrier Syst. 2000;17:61–72.
Douroumis D. Practical approaches of taste masking technologies in oral solid forms. Expert Opin Drug Deliv. 2007;4:417–26.
Mahesh A, Shastri N, Sadanandam M. Development of taste masked fast disintegrating films of levocetirizine dihydrochloride for oral use. Curr Drug Deliv. 2010;7:21–7.
Dinge A, Nagarsenker M. Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity. AAPS PharmSciTech. 2008;9:349–56.
Kearney P, Wong SK. Method for making freeze dried drug dosage forms. US Patent. 1997;5(631):023.
Al-Omran MF, Al-Suwayeh SA, El-Helw AM, Saleh SI. Taste masking of diclofenac sodium using microencapsulation. J Microencapsul. 2002;19:45–52.
Shah PP, Mashru RC, Rane YM, Thakkar A. Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking. AAPS PharmSciTech. 2008;9:377–89.
Behzadi SS, Toegel S, Viernstein H. Innovations in coating technology. Recent Pat Drug Deliv Formul. 2008;2:209–30.
Hamashita T, Matsuzaki M, Ono T, Ono M, Tsunenari Y, Aketo T, et al. Granulation of core particles suitable for film coating by agitation fluidized bed II. A proposal of a rapid dissolution test for evaluation of bitter taste of ibuprofen. Chem Pharm Bull (Tokyo). 2008;56:883–7.
Albertini B, Cavallari C, Passerini N, Voinovich D, González-Rodríguez ML, Magarotto L, et al. Characterization and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high-shear mixer. Eur J Pharm Sci. 2004;21:295–303.
Benoit JP, Rolland H, Thies C, Vande Velde V. Method of coating particles and coated spherical particles. US Patent. 2000;6(087):003.
Mazen H, York P. Particle formation methods and their products. US Patent. 2006;7(115):280.
He W, Fan LF, Du Q, Xiang B, Li CL, Bai M, et al. Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole. Chem Pharm Bull. 2009;57:122–8.
Liu Y, Liu S, Dai Q. Design and evaluation of pH-independent pulsatile release pellets containing isosorbide-5-mononitrate. Chem Pharm Bull. 2009;57:55–60.
Ji C, Xu H, Wu W. In vitro evaluation and pharmacokinetics in dogs of guar gum and Eudragit FS30D-coated colon-targeted pellets of indomethacin. J Drug Target. 2007;15:123–31.
Sugao H, Yamazaki S, Shiozawa H, Yano K. Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles. J Pharm Sci. 1998;87:96–100.
Curran MP, Scott LJ, Perry CM. Cetirizine: a review of its use in allergic disorders. Drugs. 2004;64:523–61.
Corbo M, Desai J, Patell M, Warrick R. Taste masking coating composition. US. 2002;6(663):893.
Harmon T. Beyond the first greneration of orally disintegrationg tablets. www.eurand.com/pdf/EURX_Article_Sep_2006.pdf (2006).
Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier JP, Piccerelle P. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm. 2005;292:29–41.
Khan S, Kataria P, Nakhat P, Pramod Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS PharmSciTech. 2007;8:E1–7.
Goel H, Vora N, Rana V. A novel approach to optimize and formulate fast disintegrating tablets for nausea and vomiting. AAPS PharmSciTech. 2008;9:774–81.
Peppas NA, Buri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Rel. 1985;2:257–75.
Fell JT, Newton JM. Determination of tablet strength by diametral—compression test. J Pharm Sci. 1970;59:688–91.
Tye CK, Sun CC, Amidon GE. Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction. J Pharm Sci. 2005;94:465–7.
Parrott EL. In: Lieberman HA, Lachman L, Schwartz JB, editors. “Pharmaceutical dosage forms: tablets vol. 2,”. 2nd ed. New York: Marcel Dekker; 1990. p. 201–43.
Bi YX, Sunada H, Yonezawa Y, Danjo K. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm. 1999;25:571–81.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Douroumis, D.D., Gryczke, A. & Schminke, S. Development and Evaluation of Cetirizine HCl Taste-Masked Oral Disintegrating Tablets. AAPS PharmSciTech 12, 141–151 (2011). https://doi.org/10.1208/s12249-010-9569-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-010-9569-7